繁體
  • 简体中文
  • 繁體中文

熱門資訊> 正文

Redhill Bizerma为H推出Talicia。阿联酋的pylori感染

2024-08-21 20:04

08:04 AM EDT, 08/21/2024 (MT Newswires) -- Redhill Biopharma (RDHL) said Wednesday it has launched Talicia by prescription in the United Arab Emirates to treat H. pylori infections in adults.

The company said the launch makes RedHill eligible for additional milestone payments, minimum sales payments, and tiered royalties up to the mid-teens percentage on net sales.

Talicia is a fixed-dose, all-in-one oral capsule combination of two antibiotics: amoxicillin and rifabutin, and a proton pump inhibitor, omeprazole, the company said. It was approved by the US Food and Drug Administration in 2019 for the treatment of H. pylori infection in adults.

Price: 8.74, Change: +0.21, Percent Change: +2.46

風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。